The results showed that the level of cytl1 expression was significantly lower in tumor tissues than in adjacent nontumor tissues in breast cancer patients based on data obtained from The Cancer Genome Atlas (TCGA) database (Fig. 1a). This evidence concerns the gene CYTL1 and breast carcinoma.